Minovia Therapeutics
Hanan Khoury, Ph.D. is currently working as a Translational Scientist at Minovia Therapeutics since July 2021. Prior to this, they held the position of Senior Pharmaceutical Project Manager at Salzman Group from June 2019 to July 2021 and Quality Assurance Manager at GeneSort from July 2015 to April 2019. Hanan Khoury, Ph.D. holds a Ph.D. in Epigenetics and Cancer from Technion - Israel Institute of Technology, obtained in 2015, and a Bachelor of Science in Biology from the same institution, completed in 2010.
Minovia Therapeutics
Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible. Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.